• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine Tumors.

作者信息

Pavel Marianne, de Herder Wouter W

机构信息

Department of Hepatology and Gastroenterology, ENETS Centre of Excellence, Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany.

出版信息

Neuroendocrinology. 2017;105(3):193-195. doi: 10.1159/000457957. Epub 2017 Feb 11.

DOI:10.1159/000457957
PMID:28190018
Abstract
摘要

相似文献

1
ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine Tumors.神经内分泌肿瘤治疗标准的欧洲神经内分泌肿瘤学会（ENETS）共识指南
Neuroendocrinology. 2017;105(3):193-195. doi: 10.1159/000457957. Epub 2017 Feb 11.
2
ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine Tumors.神经内分泌肿瘤护理标准的欧洲神经内分泌肿瘤学会（ENETS）共识指南。
Neuroendocrinology. 2009;90(2):159-61. doi: 10.1159/000225945. Epub 2009 Aug 28.
3
Proceedings of the 3rd ENETS Consensus Conference on Guidelines for the Standard of Care in Neuroendocrine Tumors, Palma de Mallorca, Spain, 2007.第三届神经内分泌肿瘤护理标准指南ENETS共识会议论文集，西班牙马略卡岛帕尔马，2007年
Neuroendocrinology. 2009;90(2):155-234. doi: 10.1159/000235970.
4
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors.神经内分泌肿瘤护理标准的ENETS共识指南：神经内分泌肿瘤患者的术前和围手术期治疗
Neuroendocrinology. 2017;105(3):245-254. doi: 10.1159/000461583. Epub 2017 Mar 2.
5
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors.ENETS神经内分泌肿瘤护理标准共识指南：神经内分泌肿瘤患者的化疗
Neuroendocrinology. 2009;90(2):214-9. doi: 10.1159/000225950. Epub 2009 Aug 28.
6
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours.神经内分泌肿瘤护理标准的ENETS共识指南：小肠和胰腺神经内分泌肿瘤的手术治疗
Neuroendocrinology. 2017;105(3):255-265. doi: 10.1159/000464292. Epub 2017 Feb 25.
7
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.ENETS神经内分泌肿瘤护理标准共识指南：神经内分泌肿瘤患者的术前和围手术期治疗
Neuroendocrinology. 2009;90(2):203-8. doi: 10.1159/000225949. Epub 2009 Aug 28.
8
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.ENETS神经内分泌肿瘤护理标准共识指南：迈向胃肠胰神经内分泌肿瘤诊断及其预后分层的标准化方法。
Neuroendocrinology. 2009;90(2):162-6. doi: 10.1159/000182196. Epub 2009 Aug 28.
9
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: echocardiography.神经内分泌肿瘤护理标准的欧洲神经内分泌肿瘤学会（ENETS）共识指南：超声心动图
Neuroendocrinology. 2009;90(2):190-3. doi: 10.1159/000225947. Epub 2009 Aug 28.
10
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy.神经内分泌肿瘤治疗标准的ENETS共识指南：生物疗法
Neuroendocrinology. 2009;90(2):209-13. doi: 10.1159/000183751. Epub 2009 Aug 28.

引用本文的文献

1
Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors.转移性神经内分泌肿瘤单纯栓塞术后肽受体放射性核素治疗（PRRT）的安全性和有效性
Cancers (Basel). 2024 Jul 30;16(15):2703. doi: 10.3390/cancers16152703.
2
Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future Perspectives.原发灶不明的神经内分泌肿瘤的新兴治疗选择：当前证据与未来展望
Cancers (Basel). 2024 May 27;16(11):2025. doi: 10.3390/cancers16112025.
3
Update on thymic epithelial tumors: a narrative review.
胸腺上皮肿瘤的最新进展：一篇叙述性综述
Mediastinum. 2024 Apr 26;8:33. doi: 10.21037/med-23-47. eCollection 2024.
4
Epidemiological profile of neuroendocrine tumors in adults in Brazil.巴西成年人神经内分泌肿瘤的流行病学特征。
Arch Endocrinol Metab. 2024 May 6;68:e230013. doi: 10.20945/2359-4292-2023-0013.
5
Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease.615例小肠神经内分泌肿瘤患者的预后：手术后的复发风险及晚期疾病的疾病特异性生存率
Cancers (Basel). 2024 Jan 1;16(1):204. doi: 10.3390/cancers16010204.
6
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.评估卡博替尼联合兰瑞肽治疗胃肠胰和胸神经内分泌肿瘤的安全性和活性：LOL A 试验的理论基础和方案。
BMC Cancer. 2023 Sep 26;23(1):908. doi: 10.1186/s12885-023-11287-2.
7
Real world use of lanreotide in neuroendocrine tumors.兰瑞肽在神经内分泌肿瘤中的实际应用。
J Gastrointest Oncol. 2023 Jun 30;14(3):1488-1495. doi: 10.21037/jgo-22-1182. Epub 2023 Jun 19.
8
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms.北美神经内分泌肿瘤学会关于胃肠胰和妇科神经内分泌肿瘤高级别瘤的管理的专家共识实践推荐。
Endocr Relat Cancer. 2023 Jul 11;30(8). doi: 10.1530/ERC-22-0206. Print 2023 Aug 1.
9
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.超声内镜引导下组织获取术对直径 20mm 或以下疑似神经内分泌肿瘤或需要鉴别诊断的胰腺实性病变的疗效。
J Gastroenterol. 2023 Jul;58(7):693-703. doi: 10.1007/s00535-023-01995-8. Epub 2023 May 8.
10
A systematic review of therapeutic strategies in gastroenteropancreatic grade 3 neuroendocrine tumors.胃肠胰神经内分泌3级肿瘤治疗策略的系统评价
Ther Adv Med Oncol. 2023 Mar 16;15:17588359231156218. doi: 10.1177/17588359231156218. eCollection 2023.